Equity Insider News Commentary
Issued on behalf of Oncolytics Biotech Inc.
VANCOUVER. BC, July 16, 2025 /CNW/ -- As lawmakers weigh potential cuts to scientific research...
20/20 Tax Resolution's new Spanish helpline offers free consultations to help Hispanic taxpayers resolve IRS and state tax issues like debt, levies, and wage...
Grâce à des conseillers d’élite, à une génomique de pointe et à une IA en temps réel, la plateforme de santé sportive cible les complications cardiaques, les blessures dues au surmenage, les sélections d’équipe inadéquates et les talents inexploités
Grâce à des conseillers d’élite, à une génomique de pointe et à une IA en temps réel, la plateforme de santé sportive cible les complications cardiaques, les blessures dues au surmenage, les sélections d’équipe inadéquates et les talents inexploités
Vector database technology enables intelligent automation in real estate, financial services, and beyond
SAN FRANCISCO, July 11, 2025 /PRNewswire/ -- Zilliz, the company behind the...
Appleton, WI, July 11, 2025 (GLOBE NEWSWIRE) -- Watts Lights, a North American leader in permanent smart lighting systems, and Lumenary Pro, an emerging force in the smart home sector, have announced a strategic partnership to build a national network dedicated to delivering permanent lighting systems to homes and commercial properties across the United States. Together, they’re reshaping how smart lighting is sold, serviced, and experienced by homeowners.
- Over 3,600 one-on-one meetups conducted between 250 corporates/investors and 1,100 startups from 28 countries -
- Germany, this year's featured country, dispatched official delegation;...
HONG KONG and SHANGHAI, July 4, 2025 /PRNewswire/ -- The "Global Digital Economy Conference - Cloud-Intelligence-Computing Security Forum," also known as the third "SecGo...
In this 2025 availability update, Remote Pharmacy highlights the expanded access to non-branded GLP-1-based weight management options, including semaglutide and tirzepatide compounds. The release explores the evolving role of compounded therapeutics, shifts in consumer behavior toward remote prescribing, and how new formulations align with the growing interest in safe, physician-directed care for weight management.
In this 2025 availability update, Remote Pharmacy highlights the expanded access to non-branded GLP-1-based weight management options, including semaglutide and tirzepatide compounds. The release explores the evolving role of compounded therapeutics, shifts in consumer behavior toward remote prescribing, and how new formulations align with the growing interest in safe, physician-directed care for weight management.